Drug
risankizumab-rzaa
Marketed as SKYRIZI.
Generic name
risankizumab-rzaa
Brand names
SKYRIZI
First FDA approval
2019-04-23
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761262 | SKYRIZI | 2022-06-16 | ABBVIE INC |
| BLA761105 | SKYRIZI | 2019-04-23 | ABBVIE INC |
Manufacturers
ABBVIE INC
Frequently asked questions
When was risankizumab-rzaa FDA approved?
Earliest FDA approval on record: 2019-04-23.
What brand names are sold as risankizumab-rzaa?
SKYRIZI.
Sources
Appeal a risankizumab-rzaa denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com